logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table PDU-6. Estimated trends in the prevalence of problem and injecting drug use - 2001 to 2006 (rate per 1 000 population aged 15 to 64): Combined estimates per country [see all tables in this series...]

Part (iv) Estimated trends of problem stimulant use

Country200120022003200420052006Drug usemethod
Czech Republic2.822.69PSUCM
Spain2.425.22PSUOT
Finland4.55.25.86PSUCR
Italy3.74.08PSUMI
Slovakia2.12.2PSUOT

Notes:

 Time-series are combined where methods are similar over the time span. In some countries data are insufficient to report. 

 Target groups may vary between countries owing to different methods and data sources; therefore comparisons should be made with caution. 

 For more details see Tables PDU-1, PDU-2 and PDU-3 in the Statistical bulletin 2008. 

 See also ‘General notes for interpreting data’ on the Explanatory notes and help page 

 See also EMCDDA project (2003): National prevalence estimates of problem drug use in the European Union, 1995–2000, CT.00.RTX.23, EMCDDA, Lisbon, coordinated by the Institut für Therapieforschung, Munich. 

Sources:

 Reitox national focal points 

(see the help page for information about formats etc.)

Page last updated: Wednesday, 16 July 2008